Godavari Drugs Limited

BSE:530317 Stock Report

Market Cap: ₹860.7m

Godavari Drugs Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Mukund Kakani

Chief executive officer

₹1.8m

Total compensation

CEO salary percentage100.0%
CEO tenureno data
CEO ownership20.0%
Management average tenureno data
Board average tenure11.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mukund Kakani's remuneration changed compared to Godavari Drugs's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹66m

Jun 30 2024n/an/a

₹64m

Mar 31 2024₹2m₹2m

₹55m

Dec 31 2023n/an/a

₹42m

Sep 30 2023n/an/a

₹37m

Jun 30 2023n/an/a

₹37m

Mar 31 2023₹2m₹2m

₹38m

Dec 31 2022n/an/a

₹37m

Sep 30 2022n/an/a

₹44m

Jun 30 2022n/an/a

₹47m

Mar 31 2022₹1m₹1m

₹52m

Dec 31 2021n/an/a

₹53m

Sep 30 2021n/an/a

₹49m

Jun 30 2021n/an/a

₹47m

Mar 31 2021₹1m₹1m

₹41m

Dec 31 2020n/an/a

₹36m

Sep 30 2020n/an/a

₹31m

Jun 30 2020n/an/a

₹24m

Mar 31 2020₹1m₹1m

₹20m

Dec 31 2019n/an/a

₹16m

Sep 30 2019n/an/a

₹15m

Jun 30 2019n/an/a

₹15m

Mar 31 2019₹1m₹1m

₹12m

Dec 31 2018n/an/a

₹12m

Sep 30 2018n/an/a

₹10m

Jun 30 2018n/an/a

₹9m

Mar 31 2018₹1m₹1m

₹8m

Compensation vs Market: Mukund's total compensation ($USD21.14K) is below average for companies of similar size in the Indian market ($USD42.29K).

Compensation vs Earnings: Mukund's compensation has been consistent with company performance over the past year.

CEO

Mukund Kakani (72 yo)

no data

Tenure

₹1,800,000

Compensation

Mr. Mukund Kakani serves as the Chief Executive Officer, Managing Director and Director of Godavari Drugs Ltd. He is a chemical engineer (B.Tech) from Osmania University.

Board Members

NamePositionTenureCompensationOwnership
Mukund Kakani
CEO, MD & Executive Directorno data₹1.80m19.99%
₹ 172.0m
Mohit Jaju
CFO & Whole Time Director12.6yrs₹1.80m7.1%
₹ 61.2m
Syed Hussain
Non-Executive Independent Director19yrs₹80.00kno data
Ghanshyam Jaju
Chairman18.3yrsno data16.76%
₹ 144.3m
Vimala Madon
Non-Executive Independent Director9.8yrs₹80.00kno data
Mahendra Bhalerao
Non-Executive Independent Director2.1yrs₹80.00k0.020%
₹ 171.5k
Dinesh Udpa
Non-Executive Independent Directorless than a yearno datano data

11.2yrs

Average Tenure

72yo

Average Age

Experienced Board: 530317's board of directors are seasoned and experienced ( 11.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:04
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Godavari Drugs Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research